Psychiatry does well in many instances: however there are perplexing cases that do not respond as predicted to the first and even the second medication attempt. Electroencephalography (EEG), quantitative EEG (qEEG) and genome testing provides scientific data that can help to explain the cause of the symptoms, give insight as to why the prior medications failed and gives psychiatrists valuable personalized information as to which medication will most likely work without side-effects. Merging brain mapping technology with psychiatry can maximize treatment results and measure improvement.
A diagnosis of ADHD is made when a person shows a minimum number of specific symptoms. The problem is that ADHD symptoms have many neurological and biological causes and each one is medication specific. Brain mapping technology can identify the cause of the inability to focus and this information helps a psychiatrist pinpoint the exact medication. This event is based on Drs Swatzyna’s and Tarnow’s recently published six-year study that presents the most common brain and body anomalies that create ADHD symptoms and explains how this information can assist in medication selection and treatment.